DVAX Key Stats
- Biotech Investing for Beginners Fool May 22
- Due Diligence in Finding the Value of Pharmaceuticals: Expert Portfolio Manager ... May 16
- See What These $15 Billion Managers Have Been Buying May 14
- 3 Investment Strategy Lessons From Vertex's Success May 11
- DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report May 9
- Wider-than-Expected Loss at Dynavax May 7
- Wider-than-Expected Loss at Dynavax - Analyst Blog Zacks May 7
- Dynavax Technologies Corp (DVAX) Reports In-Line Q1 EPS Street Insider May 6
- Dynavax Reports First Quarter 2013 Financial Results Marketwired May 6
- DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financia... May 6
DVAX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Dynavax Technologies Corporation is down 29.69% over the last year vs S&P 500 Total Return up 28.45%, GlaxoSmithKline up 24.84%, and Anika Therapeutics up 3.06%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for DVAX
Pro Report PDF for DVAX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download DVAX Pro Report PDF
Pro Strategies Featuring DVAX
Did Dynavax Technologies Corporation make it into our Pro Portfolio Strategies?